These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 989013)

  • 1. Dry polyacrylamide batch method for studying drug protein binding.
    Julkunen RJ; Himberg JJ
    Arzneimittelforschung; 1976 Apr; 26(4):560-3. PubMed ID: 989013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    Maes V; Engelborghs Y; Hoebeke J; Maras Y; Vercruysse A
    Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A theoretical analysis of the distribution of quinidine in the plasma: the relationship between protein binding and therapeutic drug levels.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):147-54. PubMed ID: 1188181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry polyacrylamide batch method for determining the binding of various compounds by plasma proteins.
    Himberg JJ; Julkunen RJ; Soininen KA
    Arzneimittelforschung; 1976 Feb; 26(2):177-80. PubMed ID: 947196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
    Chan E; McLachlan AJ; Rowland M
    Chirality; 1993; 5(8):610-5. PubMed ID: 8305289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin.
    O'Reilly RA
    J Clin Invest; 1969 Jan; 48(1):193-202. PubMed ID: 5765021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
    He J; Shibukawa A; Tokunaga S; Nakagawa T
    J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute.
    Parsons DL; Ravis WR; Clark CR
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):4-14. PubMed ID: 4062432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
    Albengres E; Urien S; Kusmierek J; Tillement JP
    Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
    Kragh-Hansen U; Brennan SO; Galliano M; Sugita O
    Mol Pharmacol; 1990 Feb; 37(2):238-42. PubMed ID: 2304452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of erythromycin base to human plasma proteins.
    Prandota J; Tillement JP; d'Athis P; Campos H; Barre J
    J Int Med Res; 1980; 8 Suppl 2():1-8. PubMed ID: 7429002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New aspects of free drug concentration determination in human serum with equilibrium dialysis.
    van der Giesen WF; Wilting J
    Methods Find Exp Clin Pharmacol; 1982; 4(6):417-23. PubMed ID: 7144334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of four sulphonamides to human albumin.
    Zini R; d'Athis P; Hoareau A; Tillement JP
    Eur J Clin Pharmacol; 1976 Jun; 10(2):139-45. PubMed ID: 964290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.